Indications and Purposes
| 1 Indications And Usage Alyq™ Is A Phosphodiesterase 5 (Pde5) Inhibitor Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1) To Improve Exercise Ability. Studies Establishing Effectiveness Included Predominately Patients With Nyha Functional Class Ii To Iii Symptoms And Etiologies Of Idiopathic Or Heritable Pah (61%) Or Pah Associated With Connective Tissue Diseases (23%). ( 1.1 ) 1.1 Pulmonary Arterial Hypertension Alyq™ Is Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1) To Improve Exercise Ability. Studies Establishing Effectiveness Included Predominately Patients With Nyha Functional Class Ii – Iii Symptoms And Etiologies Of Idiopathic Or Heritable Pah (61%) Or Pah Associated With Connective Tissue Diseases (23%). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Tadalafil |
|
ZINC3993855 |